Loading

Ziphius

June 04, 2024
Company Presentation
Immunology
Company Presentation Theater 1
Ziphius is a biotechnology company focused on the development of self-amplifying RNA-based (saRNA) vaccines and therapeutics based on its proprietary saRNA and carrier technology (LNP) platform to allow for a higher and prolonged protein/antigen expression at lower doses (compared to conventional mRNA) with reduced toxicity. This platform has the potential for a ‘plug and play’ approach offering the possibility of fast development/scale-up and production. These attributes makes it well suited as platform to improve pandemic preparedness.
Ziphius
Company Website: http://www.ziphius.org
Lead Product in Development: Infectious disease vaccine

Company HQ City

New York

Company HQ State

New York

Company HQ Country

United States

CEO/Top Company Official

Chris Cardon

Development Phase of Primary Product

Pre-Clinical
Speakers
Chris Cardon
CEO
Ziphius
Back to Session List

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS